PUBLISHER: The Business Research Company | PRODUCT CODE: 1945285
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945285
Hemoglobin testing is a medical procedure designed to measure the concentration of hemoglobin in the blood. Hemoglobin, a protein found in red blood cells, plays a crucial role in transporting oxygen from the lungs to the tissues and organs of the body.
The primary types of products in hemoglobin testing include reagents and consumables, as well as equipment. The reagents and consumables segment in the hemoglobin testing market encompasses various chemical reagents and consumable products utilized in the process of hemoglobin testing. Various technologies are employed for hemoglobin testing, including chromatography, immunoassay, spectrophotometry, and others. These testing products find application in diverse settings such as hospitals, clinics, laboratories, home care settings, blood banks, and others.
Tariffs are influencing the hemoglobin testing market by increasing costs of imported diagnostic reagents, analyzers, sensors, and electronic components used in laboratory and point-of-care testing devices. Hospitals and diagnostic laboratories in North America and Europe are most affected due to reliance on imported testing equipment, while Asia-Pacific faces cost pressure on manufacturing consumables for export. These tariffs are increasing testing costs and procurement expenses. However, they are also encouraging local production of diagnostic kits, regional assembly of analyzers, and innovation in cost-efficient testing solutions.
The hemoglobin testing market research report is one of a series of new reports from The Business Research Company that provides hemoglobin testing market statistics, including hemoglobin testing industry global market size, regional shares, competitors with a hemoglobin testing market share, detailed hemoglobin testing market segments, market trends and opportunities, and any further data you may need to thrive in the hemoglobin testing industry. This hemoglobin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemoglobin testing market size has grown strongly in recent years. It will grow from $2.79 billion in 2025 to $3.03 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to expansion of routine blood testing practices, growth in anemia screening programs, increasing hospital diagnostic workloads, availability of cost-effective testing kits, rising public health initiatives.
The hemoglobin testing market size is expected to see strong growth in the next few years. It will grow to $4.28 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for decentralized diagnostics, rising adoption of home testing devices, expansion of digital health monitoring, growing focus on early disease detection, continuous innovation in diagnostic accuracy. Major trends in the forecast period include increasing adoption of point-of-care hemoglobin testing, rising use of portable hemoglobin analyzers, growing demand for rapid blood screening, expansion of home-based diagnostic testing, enhanced focus on preventive health screening.
The hemoglobin testing market is poised for growth, driven by the increasing prevalence of chronic disorders such as diabetes. Diabetes, a chronic condition characterized by insufficient insulin production or utilization, necessitates regular monitoring through Hemoglobin A1c tests (HbA1c). These tests, recommended by the American Diabetes Association, play a crucial role in diabetes diagnosis. With over 34 million Americans having diabetes and an additional 88 million at risk, the demand for HbA1c testing devices is set to rise. Furthermore, global projections indicate a substantial increase in diabetes cases, reaching 783,700 individuals by 2045, emphasizing the pivotal role of hemoglobin A1c testing devices in managing chronic disorders.
Leading companies in the hemoglobin testing market are creating innovative fingerstick blood test solutions to enable patients to conveniently monitor their hemoglobin levels at home, support early detection of anemia, and enhance overall health management. These advanced fingerstick blood test methods allow for quick and easy blood sample collection through a simple finger prick, making diagnostic testing more efficient and less invasive. For example, in February 2024, Sanguina Inc., a health technology company based in the U.S., launched AnemoCheck Home, the first FDA-cleared home hemoglobin test kit. AnemoCheck Home is designed to provide users with accurate hemoglobin readings using a simple finger prick. This user-friendly kit includes all the necessary components, such as a testing device and clear instructions, enabling individuals to conduct the test without needing a laboratory visit. AnemoCheck Home not only allows patients to regularly monitor their hemoglobin levels but also promotes early detection of potential health issues like anemia.
In July 2024, F. Hoffmann-La Roche Ltd., a Switzerland-based biotechnology and diagnostics leader, acquired LumiraDx for an undisclosed amount. Through this acquisition, Roche aims to expand its decentralized testing capabilities and improve global access to primary care diagnostics, particularly in low- and middle-income regions. LumiraDx Ltd., based in the UK, specializes in hemoglobin testing, including its HbA1c assay.
Major companies operating in the hemoglobin testing market are Abbott Laboratories Inc, F Hoffmann La Roche Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Bio Rad Laboratories Inc, Sysmex Corporation, Siemens Healthineers AG, Mindray Medical International Limited, Nihon Kohden Corporation, EKF Diagnostics Holdings plc, ARKRAY Inc, Nova Biomedical Corporation, Beckman Coulter Inc, Radiometer A S, DiaSys Diagnostic Systems GmbH, Erba Diagnostics Inc, Tosoh Corporation, ACON Laboratories Inc, Diazyme Laboratories Inc, Humasis Co Ltd, BioMedomics Inc, NanoEntek Inc
Asia-Pacific was the largest regions in the hemoglobin testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global hemoglobin testing market report during the forecast period. The regions covered in the hemoglobin testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hemoglobin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hemoglobin testing market consists of revenues earned by entities by providing services such as hemoglobin-cyanide, vanzetti's azide methemoglobin, reagent-less, non-invasive methods, and hemoglobin electrophoresis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemoglobin Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hemoglobin testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hemoglobin testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemoglobin testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.